BRPI0719923B1 - Métodos para sequenciamento de um ácido nucléico alvo, para conversão de um componente de ocorrência não natural em uma molécula de ácido nucléico em um componente de ocorrência natural, para terminar uma síntese de ácido nucléico, e para realizar o sequenciamento de sanger ou tipo sanger, e compostos - Google Patents
Métodos para sequenciamento de um ácido nucléico alvo, para conversão de um componente de ocorrência não natural em uma molécula de ácido nucléico em um componente de ocorrência natural, para terminar uma síntese de ácido nucléico, e para realizar o sequenciamento de sanger ou tipo sanger, e compostos Download PDFInfo
- Publication number
- BRPI0719923B1 BRPI0719923B1 BRPI0719923-6A BRPI0719923A BRPI0719923B1 BR PI0719923 B1 BRPI0719923 B1 BR PI0719923B1 BR PI0719923 A BRPI0719923 A BR PI0719923A BR PI0719923 B1 BRPI0719923 B1 BR PI0719923B1
- Authority
- BR
- Brazil
- Prior art keywords
- mmol
- compound
- triphosphate
- solution
- polymerase
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 70
- 150000001875 compounds Chemical class 0.000 title claims description 195
- 108020004707 nucleic acids Proteins 0.000 title claims description 54
- 102000039446 nucleic acids Human genes 0.000 title claims description 54
- 150000007523 nucleic acids Chemical class 0.000 title claims description 54
- 238000012163 sequencing technique Methods 0.000 title claims description 45
- 239000002253 acid Substances 0.000 title claims description 3
- 238000003786 synthesis reaction Methods 0.000 title description 86
- 230000015572 biosynthetic process Effects 0.000 title description 84
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 91
- 239000002773 nucleotide Substances 0.000 claims abstract description 86
- 239000002777 nucleoside Substances 0.000 claims abstract description 81
- 150000003833 nucleoside derivatives Chemical class 0.000 claims abstract description 27
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 23
- 230000006820 DNA synthesis Effects 0.000 claims abstract description 15
- 239000001226 triphosphate Substances 0.000 claims description 125
- 235000011178 triphosphate Nutrition 0.000 claims description 112
- -1 2-nitrophenyl Chemical group 0.000 claims description 100
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 claims description 95
- 238000006243 chemical reaction Methods 0.000 claims description 84
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 59
- 239000007787 solid Substances 0.000 claims description 55
- 239000000975 dye Substances 0.000 claims description 52
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 46
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 46
- 238000010348 incorporation Methods 0.000 claims description 41
- 230000005284 excitation Effects 0.000 claims description 40
- 125000003118 aryl group Chemical group 0.000 claims description 28
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 125000005647 linker group Chemical group 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 239000001177 diphosphate Substances 0.000 claims description 10
- 235000011180 diphosphates Nutrition 0.000 claims description 10
- 125000001624 naphthyl group Chemical group 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- 150000004712 monophosphates Chemical class 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 7
- 239000000758 substrate Substances 0.000 claims description 7
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000003367 polycyclic group Chemical group 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims description 4
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 claims description 4
- 125000000304 alkynyl group Chemical group 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 claims description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 4
- 150000004820 halides Chemical class 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 238000001668 nucleic acid synthesis Methods 0.000 claims description 4
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 4
- 108060006184 phycobiliprotein Proteins 0.000 claims description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 4
- 238000012546 transfer Methods 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 229910052727 yttrium Inorganic materials 0.000 claims description 4
- 125000003456 2,6-dinitrophenyl group Chemical group [H]C1=C([H])C(=C(*)C(=C1[H])[N+]([O-])=O)[N+]([O-])=O 0.000 claims description 3
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims description 3
- 108010006785 Taq Polymerase Proteins 0.000 claims description 3
- 108010001244 Tli polymerase Proteins 0.000 claims description 3
- 125000005842 heteroatom Chemical group 0.000 claims description 3
- 238000003384 imaging method Methods 0.000 claims description 3
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 claims description 3
- 230000000295 complement effect Effects 0.000 claims description 2
- 239000003999 initiator Substances 0.000 claims description 2
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 claims 2
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 claims 2
- 102100034343 Integrase Human genes 0.000 claims 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims 2
- 238000006555 catalytic reaction Methods 0.000 claims 2
- 238000001712 DNA sequencing Methods 0.000 abstract description 26
- 238000005516 engineering process Methods 0.000 abstract description 22
- 125000003835 nucleoside group Chemical group 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 275
- 239000000243 solution Substances 0.000 description 239
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 139
- 239000000203 mixture Substances 0.000 description 130
- 238000005160 1H NMR spectroscopy Methods 0.000 description 116
- 229910052739 hydrogen Inorganic materials 0.000 description 114
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 107
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 105
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 104
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 102
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 90
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 84
- VKIGAWAEXPTIOL-UHFFFAOYSA-N 2-hydroxyhexanenitrile Chemical compound CCCCC(O)C#N VKIGAWAEXPTIOL-UHFFFAOYSA-N 0.000 description 79
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 78
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 72
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 71
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 64
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 63
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 63
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 229910019213 POCl3 Inorganic materials 0.000 description 52
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 50
- 239000006260 foam Substances 0.000 description 49
- 238000010898 silica gel chromatography Methods 0.000 description 49
- 235000017557 sodium bicarbonate Nutrition 0.000 description 41
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 41
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 40
- 150000001793 charged compounds Chemical class 0.000 description 38
- 238000004440 column chromatography Methods 0.000 description 38
- 239000000741 silica gel Substances 0.000 description 38
- 229910002027 silica gel Inorganic materials 0.000 description 38
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 37
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 36
- OIJLNRJUJLVSEX-LKVHNBMWSA-N [[(2r,3s,5r)-5-[2-amino-6-[1-[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]ethoxy]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCN)C=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(N)=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 OIJLNRJUJLVSEX-LKVHNBMWSA-N 0.000 description 36
- 235000017550 sodium carbonate Nutrition 0.000 description 36
- 229910000029 sodium carbonate Inorganic materials 0.000 description 36
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 33
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 description 30
- 239000011541 reaction mixture Substances 0.000 description 29
- 238000004007 reversed phase HPLC Methods 0.000 description 29
- 239000007832 Na2SO4 Substances 0.000 description 28
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 28
- 239000000872 buffer Substances 0.000 description 28
- 229910052938 sodium sulfate Inorganic materials 0.000 description 28
- 235000011152 sodium sulphate Nutrition 0.000 description 28
- 238000003756 stirring Methods 0.000 description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 27
- NCGWKCHAJOUDHQ-UHFFFAOYSA-N n,n-diethylethanamine;formic acid Chemical compound OC=O.OC=O.CCN(CC)CC NCGWKCHAJOUDHQ-UHFFFAOYSA-N 0.000 description 27
- 239000012044 organic layer Substances 0.000 description 27
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 27
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 26
- 235000011114 ammonium hydroxide Nutrition 0.000 description 26
- WRMXOVHLRUVREB-UHFFFAOYSA-N phosphono phosphate;tributylazanium Chemical compound OP(O)(=O)OP([O-])([O-])=O.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC WRMXOVHLRUVREB-UHFFFAOYSA-N 0.000 description 25
- WQZIDRAQTRIQDX-UHFFFAOYSA-N 6-carboxy-x-rhodamine Chemical compound OC(=O)C1=CC=C(C([O-])=O)C=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 WQZIDRAQTRIQDX-UHFFFAOYSA-N 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 238000007792 addition Methods 0.000 description 23
- 238000000746 purification Methods 0.000 description 23
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 22
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 22
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 22
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 22
- 238000004128 high performance liquid chromatography Methods 0.000 description 22
- 239000011734 sodium Substances 0.000 description 22
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 22
- GAUSMJHDHCSZOX-UHFFFAOYSA-N 2,2,2-trifluoro-n-prop-2-ynylacetamide Chemical compound FC(F)(F)C(=O)NCC#C GAUSMJHDHCSZOX-UHFFFAOYSA-N 0.000 description 21
- 238000004679 31P NMR spectroscopy Methods 0.000 description 20
- IDLISIVVYLGCKO-UHFFFAOYSA-N 6-carboxy-4',5'-dichloro-2',7'-dimethoxyfluorescein Chemical compound O1C(=O)C2=CC=C(C(O)=O)C=C2C21C1=CC(OC)=C(O)C(Cl)=C1OC1=C2C=C(OC)C(O)=C1Cl IDLISIVVYLGCKO-UHFFFAOYSA-N 0.000 description 20
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 20
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 20
- 238000005571 anion exchange chromatography Methods 0.000 description 20
- 230000008033 biological extinction Effects 0.000 description 20
- 230000002829 reductive effect Effects 0.000 description 20
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 19
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 19
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 18
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 17
- 238000001179 sorption measurement Methods 0.000 description 17
- 238000004611 spectroscopical analysis Methods 0.000 description 17
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 17
- 239000012298 atmosphere Substances 0.000 description 16
- 238000010511 deprotection reaction Methods 0.000 description 16
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 14
- 238000003556 assay Methods 0.000 description 14
- 239000000908 ammonium hydroxide Substances 0.000 description 13
- 239000010410 layer Substances 0.000 description 13
- 239000012299 nitrogen atmosphere Substances 0.000 description 13
- 125000006239 protecting group Chemical group 0.000 description 13
- 230000002441 reversible effect Effects 0.000 description 13
- VDABVNMGKGUPEY-UHFFFAOYSA-N 6-carboxyfluorescein succinimidyl ester Chemical compound C=1C(O)=CC=C2C=1OC1=CC(O)=CC=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O VDABVNMGKGUPEY-UHFFFAOYSA-N 0.000 description 12
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- 229940113082 thymine Drugs 0.000 description 12
- 229930024421 Adenine Natural products 0.000 description 11
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 11
- 229960000643 adenine Drugs 0.000 description 11
- 229940104302 cytosine Drugs 0.000 description 11
- 239000000706 filtrate Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 229940035893 uracil Drugs 0.000 description 11
- HXBMIQJOSHZCFX-UHFFFAOYSA-N 1-(bromomethyl)-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1CBr HXBMIQJOSHZCFX-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 9
- 229910004298 SiO 2 Inorganic materials 0.000 description 9
- UUVBVONAGUSCCH-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4',5'-dichloro-3',6'-dihydroxy-2',7'-dimethoxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carboxylate Chemical compound ClC1=C(O)C(OC)=CC2=C1OC1=C(Cl)C(O)=C(OC)C=C1C2(C1=C2)OC(=O)C1=CC=C2C(=O)ON1C(=O)CCC1=O UUVBVONAGUSCCH-UHFFFAOYSA-N 0.000 description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- UWYAACMYPJUURZ-UHFFFAOYSA-N 1-(2-nitrophenyl)ethanamine Chemical compound CC(N)C1=CC=CC=C1[N+]([O-])=O UWYAACMYPJUURZ-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- 125000004122 cyclic group Chemical group 0.000 description 8
- 238000010828 elution Methods 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- 239000012267 brine Substances 0.000 description 7
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- DSDBYQDNNWCLHL-UHFFFAOYSA-N 1-(2-nitrophenyl)ethanol Chemical compound CC(O)C1=CC=CC=C1[N+]([O-])=O DSDBYQDNNWCLHL-UHFFFAOYSA-N 0.000 description 6
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 6
- OIRDTQYFTABQOQ-KQYNXXCUSA-N Adenosine Natural products C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 6
- 239000002808 molecular sieve Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000002342 ribonucleoside Substances 0.000 description 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 6
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000001588 bifunctional effect Effects 0.000 description 5
- 239000005549 deoxyribonucleoside Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- BWRBVBFLFQKBPT-UHFFFAOYSA-N (2-nitrophenyl)methanol Chemical compound OCC1=CC=CC=C1[N+]([O-])=O BWRBVBFLFQKBPT-UHFFFAOYSA-N 0.000 description 4
- DMOPRQSYYMKIHH-UHFFFAOYSA-N (4-iodo-2-nitrophenyl)methanol Chemical compound OCC1=CC=C(I)C=C1[N+]([O-])=O DMOPRQSYYMKIHH-UHFFFAOYSA-N 0.000 description 4
- RASJKVJMEDIDJG-UHFFFAOYSA-N 1-(4-iodo-2-nitrophenyl)ethanol Chemical compound CC(O)C1=CC=C(I)C=C1[N+]([O-])=O RASJKVJMEDIDJG-UHFFFAOYSA-N 0.000 description 4
- LKEXBDWKOKZZAB-UHFFFAOYSA-N 1-(bromomethyl)-4-iodo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(I)=CC=C1CBr LKEXBDWKOKZZAB-UHFFFAOYSA-N 0.000 description 4
- PVJZBZSCGJAWNG-UHFFFAOYSA-N 2,4,6-trimethylbenzenesulfonyl chloride Chemical compound CC1=CC(C)=C(S(Cl)(=O)=O)C(C)=C1 PVJZBZSCGJAWNG-UHFFFAOYSA-N 0.000 description 4
- COCMHKNAGZHBDZ-UHFFFAOYSA-N 4-carboxy-3-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]benzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C1=CC(C([O-])=O)=CC=C1C(O)=O COCMHKNAGZHBDZ-UHFFFAOYSA-N 0.000 description 4
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 4
- 239000004342 Benzoyl peroxide Substances 0.000 description 4
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-L PdCl2(PPh3)2 Substances [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
- 108091036333 Rapid DNA Proteins 0.000 description 4
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 4
- 241001582429 Tetracis Species 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- GWBBFXWEJPCIIJ-BFHYXJOUSA-N [[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-[(2-nitrophenyl)methoxy]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O([C@H]1C[C@@H](O[C@@H]1COP(O)(=O)OP(O)(=O)OP(O)(O)=O)N1C=2N=CN=C(C=2N=C1)N)CC1=CC=CC=C1[N+]([O-])=O GWBBFXWEJPCIIJ-BFHYXJOUSA-N 0.000 description 4
- ZLIVJDKBCHPZBI-GVDBMIGSSA-N [[(2r,3s,5r)-5-[6-[[4-(3-aminopropyl)-2-nitrophenyl]methylamino]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound [O-][N+](=O)C1=CC(CCCN)=CC=C1CNC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 ZLIVJDKBCHPZBI-GVDBMIGSSA-N 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 4
- 229960002684 aminocaproic acid Drugs 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 235000019400 benzoyl peroxide Nutrition 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- AOJDZKCUAATBGE-UHFFFAOYSA-N bromomethane Chemical compound Br[CH2] AOJDZKCUAATBGE-UHFFFAOYSA-N 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- VGONTNSXDCQUGY-UHFFFAOYSA-N desoxyinosine Natural products C1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 VGONTNSXDCQUGY-UHFFFAOYSA-N 0.000 description 4
- 239000012973 diazabicyclooctane Substances 0.000 description 4
- 230000000977 initiatory effect Effects 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- UQPUONNXJVWHRM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UQPUONNXJVWHRM-UHFFFAOYSA-N 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 4
- 102000054765 polymorphisms of proteins Human genes 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000002953 preparative HPLC Methods 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 4
- 238000007480 sanger sequencing Methods 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- 229940104230 thymidine Drugs 0.000 description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 4
- 229940045145 uridine Drugs 0.000 description 4
- 238000012070 whole genome sequencing analysis Methods 0.000 description 4
- QJDFQDBWBVTRBK-MOBHLTHFSA-N (2r,3s,5r)-2-(hydroxymethyl)-5-[6-[1-(2-nitrophenyl)ethylamino]purin-9-yl]oxolan-3-ol Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 QJDFQDBWBVTRBK-MOBHLTHFSA-N 0.000 description 3
- JNNXEIRYDNIWPX-UHFFFAOYSA-N 1-(4-iodo-2-nitrophenyl)ethanamine Chemical compound CC(N)C1=CC=C(I)C=C1[N+]([O-])=O JNNXEIRYDNIWPX-UHFFFAOYSA-N 0.000 description 3
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 3
- JAPYIBBSTJFDAK-UHFFFAOYSA-N 2,4,6-tri(propan-2-yl)benzenesulfonyl chloride Chemical compound CC(C)C1=CC(C(C)C)=C(S(Cl)(=O)=O)C(C(C)C)=C1 JAPYIBBSTJFDAK-UHFFFAOYSA-N 0.000 description 3
- JLBVMHMZRLDVCX-UHFFFAOYSA-N 2-(2-nitrophenyl)ethyl carbamate Chemical compound NC(=O)OCCC1=CC=CC=C1[N+]([O-])=O JLBVMHMZRLDVCX-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- BYARZGJJUGCIHN-RRFJBIMHSA-N [O-][N+](=O)C1=CC(OC)=CC=C1CNC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)C1 Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1CNC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)C1 BYARZGJJUGCIHN-RRFJBIMHSA-N 0.000 description 3
- SJGWNVSUKGWMKO-YNEHKIRRSA-N [[(2r,3s,5r)-5-[2-amino-6-[(2-nitrophenyl)methoxy]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=12N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C3)C2=NC(N)=NC=1OCC1=CC=CC=C1[N+]([O-])=O SJGWNVSUKGWMKO-YNEHKIRRSA-N 0.000 description 3
- VXQKGDQDNFWXEU-ARFHVFGLSA-N [[(2r,3s,5r)-5-[2-amino-6-[[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]methoxy]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound [O-][N+](=O)C1=CC(C#CCN)=CC=C1COC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 VXQKGDQDNFWXEU-ARFHVFGLSA-N 0.000 description 3
- WKINBIVZACRULU-BFHYXJOUSA-N [[(2r,3s,5r)-5-[6-(benzylamino)purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C2=NC=NC(NCC=3C=CC=CC=3)=C2N=C1 WKINBIVZACRULU-BFHYXJOUSA-N 0.000 description 3
- WBPHJTQOTDDMOW-RNEQGDNISA-N [[(2r,3s,5r)-5-[6-[1-[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]ethylamino]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCN)C=C([N+]([O-])=O)C=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 WBPHJTQOTDDMOW-RNEQGDNISA-N 0.000 description 3
- FYZYTRWHPLTKLF-RRFJBIMHSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[5-[(2-nitrophenyl)methoxymethyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C(COCC=2C(=CC=CC=2)[N+]([O-])=O)=C1 FYZYTRWHPLTKLF-RRFJBIMHSA-N 0.000 description 3
- 229960005305 adenosine Drugs 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000005546 dideoxynucleotide Substances 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000000524 positive electrospray ionisation mass spectrometry Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 238000000825 ultraviolet detection Methods 0.000 description 3
- XUHNCQCAWCIYFT-BPBQHXEFSA-N (2r,3s,5r)-2-(hydroxymethyl)-5-[6-[1-(4-iodo-2-nitrophenyl)ethylamino]purin-9-yl]oxolan-3-ol Chemical compound C=1C=C(I)C=C([N+]([O-])=O)C=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 XUHNCQCAWCIYFT-BPBQHXEFSA-N 0.000 description 2
- HLCLTOJXMUXWQW-UHFFFAOYSA-N 1-(4-iodophenyl)ethanamine Chemical compound CC(N)C1=CC=C(I)C=C1 HLCLTOJXMUXWQW-UHFFFAOYSA-N 0.000 description 2
- BQTRMYJYYNQQGK-UHFFFAOYSA-N 1-(bromomethyl)-4-iodobenzene Chemical compound BrCC1=CC=C(I)C=C1 BQTRMYJYYNQQGK-UHFFFAOYSA-N 0.000 description 2
- WZFGFNGYZZHELE-UHFFFAOYSA-N 1-(bromomethyl)-4-methoxy-2-nitrobenzene Chemical compound COC1=CC=C(CBr)C([N+]([O-])=O)=C1 WZFGFNGYZZHELE-UHFFFAOYSA-N 0.000 description 2
- GDNNSUMROMMBNC-UZTGATDUSA-N 1-[(2R,3R,4S,5R)-3,4-bis[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]pyrimidine-2,4-dione Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1([C@@H](O[C@@H]([C@]1(O)[Si](C)(C)C(C)(C)C)CO[Si](C)(C)C(C)(C)C)N1C(=O)NC(=O)C=C1)O GDNNSUMROMMBNC-UZTGATDUSA-N 0.000 description 2
- XDWSENBQVMHNGI-QLVMHMETSA-N 1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C(=O)NC(=O)C=C1)O XDWSENBQVMHNGI-QLVMHMETSA-N 0.000 description 2
- NOMYCKVOFCYYEW-RRFJBIMHSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(4-iodo-2-nitrophenyl)methoxymethyl]pyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(COCC=2C(=CC(I)=CC=2)[N+]([O-])=O)=C1 NOMYCKVOFCYYEW-RRFJBIMHSA-N 0.000 description 2
- VWLFWMUPUJSJNV-LNAREIQUSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[[1-(4-iodo-2-nitrophenyl)-2-methylpropoxy]methyl]pyrimidine-2,4-dione Chemical compound C=1C=C(I)C=C([N+]([O-])=O)C=1C(C(C)C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 VWLFWMUPUJSJNV-LNAREIQUSA-N 0.000 description 2
- ATQYQEZERUBCBG-OZVIIMIRSA-N 1-[(2s,4s,5r)-2-dimethylsilyl-4-hydroxy-5-[(2-methylpropan-2-yl)oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound C1=C(C)C(=O)NC(=O)N1[C@@]1([SiH](C)C)C[C@H](O)[C@@H](COC(C)(C)C)O1 ATQYQEZERUBCBG-OZVIIMIRSA-N 0.000 description 2
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 description 2
- PXYLHNROFAPEHM-UHFFFAOYSA-N 2-[1-(2-nitrophenyl)ethyl]isoindole-1,3-dione Chemical compound O=C1C2=CC=CC=C2C(=O)N1C(C)C1=CC=CC=C1[N+]([O-])=O PXYLHNROFAPEHM-UHFFFAOYSA-N 0.000 description 2
- PAOQTZWNYMMSEE-UHFFFAOYSA-N 2-[3-(dimethylamino)-6-dimethylazaniumylidenexanthen-9-yl]-4-(2,5-dioxopyrrolidin-1-yl)oxycarbonylbenzoate Chemical compound C=12C=CC(=[N+](C)C)C=C2OC2=CC(N(C)C)=CC=C2C=1C(C(=CC=1)C([O-])=O)=CC=1C(=O)ON1C(=O)CCC1=O PAOQTZWNYMMSEE-UHFFFAOYSA-N 0.000 description 2
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
- NUIHQWAWDWCFML-UHFFFAOYSA-N 2-methyl-1-(2-nitrophenyl)propan-1-ol Chemical compound CC(C)C(O)C1=CC=CC=C1[N+]([O-])=O NUIHQWAWDWCFML-UHFFFAOYSA-N 0.000 description 2
- LBCPVOLGOKOXIW-QLVMHMETSA-N 4-amino-1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]pyrimidin-2-one Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C(=O)N=C(N)C=C1)O LBCPVOLGOKOXIW-QLVMHMETSA-N 0.000 description 2
- OLXZPDWKRNYJJZ-UHFFFAOYSA-N 5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol Chemical compound C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(CO)O1 OLXZPDWKRNYJJZ-UHFFFAOYSA-N 0.000 description 2
- WDXDPVNSVDQEBA-DRSNIGMVSA-N 5-(bromomethyl)-1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]pyrimidine-2,4-dione Chemical compound BrCC=1C(NC(N([C@H]2C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O2)[Si](C)(C)C(C)(C)C)C=1)=O)=O WDXDPVNSVDQEBA-DRSNIGMVSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- FUFCYEMCAZMTSU-IPMKNSEASA-N 9-[(2r,4s,5r)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-[(2-nitrophenyl)methoxy]oxolan-2-yl]purin-6-amine Chemical compound O([C@H]1C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C2=NC=NC(N)=C2N=C1)CC1=CC=CC=C1[N+]([O-])=O FUFCYEMCAZMTSU-IPMKNSEASA-N 0.000 description 2
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- YWAZGFUDKTUPAQ-GZBFAFLISA-N C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NCC=2C(=CC=CC=2)[N+]([O-])=O)C=C1 Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NCC=2C(=CC=CC=2)[N+]([O-])=O)C=C1 YWAZGFUDKTUPAQ-GZBFAFLISA-N 0.000 description 2
- RYAGEMURJCIZCL-BFHYXJOUSA-N C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C(=CC=CC=3)[N+]([O-])=O)=C2N=C1 Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C(=CC=CC=3)[N+]([O-])=O)=C2N=C1 RYAGEMURJCIZCL-BFHYXJOUSA-N 0.000 description 2
- 0 COc(cc(C(c1c(*)ccc(C(NCC#Cc2cc([N+]([O-])=O)c(COCC(C(N3)=O)=CN(C(C4)OC(COP(OC)(OP5(OP(O)(OC)=[*-]5)=O)=O)=C4O)C3=O)cc2)=O)c1)=C(C=C(C1=O)OC)C(O2)=C1Cl)c2c1Cl)c1O Chemical compound COc(cc(C(c1c(*)ccc(C(NCC#Cc2cc([N+]([O-])=O)c(COCC(C(N3)=O)=CN(C(C4)OC(COP(OC)(OP5(OP(O)(OC)=[*-]5)=O)=O)=C4O)C3=O)cc2)=O)c1)=C(C=C(C1=O)OC)C(O2)=C1Cl)c2c1Cl)c1O 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 208000028782 Hereditary disease Diseases 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 208000024556 Mendelian disease Diseases 0.000 description 2
- 229910019445 Mg(ClO4) Inorganic materials 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- SQGTVEZYOFHRJF-XCGNWRKASA-N [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C=NC=2C(O)=NC=NC1=2)O Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C=NC=2C(O)=NC=NC1=2)O SQGTVEZYOFHRJF-XCGNWRKASA-N 0.000 description 2
- XUXAKOTZYZVNNG-GIAKGRAHSA-N [[(2r,3s,4r,5r)-3,4-dihydroxy-5-[4-[1-(2-nitrophenyl)ethylamino]-2-oxopyrimidin-1-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)NC(=NC1=O)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XUXAKOTZYZVNNG-GIAKGRAHSA-N 0.000 description 2
- OWOPITMQRDQZQT-IPCIMUCLSA-N [[(2r,3s,5r)-5-[2-amino-6-[1-(2-nitrophenyl)ethoxy]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(N)=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 OWOPITMQRDQZQT-IPCIMUCLSA-N 0.000 description 2
- FEHWDJKKCDSLEK-LZLYRXPVSA-N [[(2r,3s,5r)-5-[4-[[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]methylamino]-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound [O-][N+](=O)C1=CC(C#CCN)=CC=C1CNC1=NC(=O)N([C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C2)C=C1 FEHWDJKKCDSLEK-LZLYRXPVSA-N 0.000 description 2
- DXGXBGSFQFWLCC-PXVVHIOLSA-N [[(2r,3s,5r)-5-[4-amino-5-[1-(2-nitrophenyl)ethoxymethyl]-2-oxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OCC(C(=NC1=O)N)=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 DXGXBGSFQFWLCC-PXVVHIOLSA-N 0.000 description 2
- OWAHEGAWEHKMSJ-HJMBMXFBSA-N [[(2r,3s,5r)-5-[5-[1-[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]ethoxymethyl]-2,4-dioxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCN)C=C([N+]([O-])=O)C=1C(C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 OWAHEGAWEHKMSJ-HJMBMXFBSA-N 0.000 description 2
- SFIDAKUBYZQQFP-HVZPKCFKSA-N [[(2r,3s,5r)-5-[5-[[1-[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]-2-methylpropoxy]methyl]-2,4-dioxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCN)C=C([N+]([O-])=O)C=1C(C(C)C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SFIDAKUBYZQQFP-HVZPKCFKSA-N 0.000 description 2
- DNDAIMXADCXOEN-RCCFBDPRSA-N [[(2r,3s,5r)-5-[5-[[4-(3-aminoprop-1-ynyl)-2-nitrophenyl]methoxymethyl]-2,4-dioxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound [O-][N+](=O)C1=CC(C#CCN)=CC=C1COCC(C(NC1=O)=O)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 DNDAIMXADCXOEN-RCCFBDPRSA-N 0.000 description 2
- URKTYUAAKZEVPD-GZBFAFLISA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[4-[(2-nitrophenyl)methylamino]-2-oxopyrimidin-1-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)N=C(NCC=2C(=CC=CC=2)[N+]([O-])=O)C=C1 URKTYUAAKZEVPD-GZBFAFLISA-N 0.000 description 2
- JGVJTODBLNVKMB-PXVVHIOLSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[5-[1-(2-nitrophenyl)ethoxymethyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 JGVJTODBLNVKMB-PXVVHIOLSA-N 0.000 description 2
- KDRSMKIVLLJHLD-LNAREIQUSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[5-[[2-methyl-1-(2-nitrophenyl)propoxy]methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C(C)C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 KDRSMKIVLLJHLD-LNAREIQUSA-N 0.000 description 2
- MOKZWUGOARBGKH-RRFJBIMHSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[5-methyl-3-[(2-nitrophenyl)methyl]-2,4-dioxopyrimidin-1-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N(CC=2C(=CC=CC=2)[N+]([O-])=O)C(=O)C(C)=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 MOKZWUGOARBGKH-RRFJBIMHSA-N 0.000 description 2
- ACQDOHDVCUTUFM-BFHYXJOUSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[6-[(2-nitrophenyl)methylamino]purin-9-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C2=NC=NC(NCC=3C(=CC=CC=3)[N+]([O-])=O)=C2N=C1 ACQDOHDVCUTUFM-BFHYXJOUSA-N 0.000 description 2
- JQSQEBDHGTXALU-RRFJBIMHSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[6-[(4-methoxy-2-nitrophenyl)methylamino]purin-9-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound [O-][N+](=O)C1=CC(OC)=CC=C1CNC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 JQSQEBDHGTXALU-RRFJBIMHSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- JZOIZKBKSZMVRV-UHFFFAOYSA-N benzo(a)triphenylene Chemical compound C1=CC=CC2=C3C4=CC=CC=C4C=CC3=C(C=CC=C3)C3=C21 JZOIZKBKSZMVRV-UHFFFAOYSA-N 0.000 description 2
- RROBIDXNTUAHFW-UHFFFAOYSA-N benzotriazol-1-yloxy-tris(dimethylamino)phosphanium Chemical compound C1=CC=C2N(O[P+](N(C)C)(N(C)C)N(C)C)N=NC2=C1 RROBIDXNTUAHFW-UHFFFAOYSA-N 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 238000003366 endpoint assay Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- AKRYBBWYDSDZHG-UHFFFAOYSA-N nitrosobis(2-oxopropyl)amine Chemical compound CC(=O)CN(N=O)CC(C)=O AKRYBBWYDSDZHG-UHFFFAOYSA-N 0.000 description 2
- 229940127073 nucleoside analogue Drugs 0.000 description 2
- 230000005257 nucleotidylation Effects 0.000 description 2
- 238000002966 oligonucleotide array Methods 0.000 description 2
- SWFDTFBWXCNRGN-UHFFFAOYSA-N phosphonato phosphate;tributylazanium Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC.CCCC[NH+](CCCC)CCCC SWFDTFBWXCNRGN-UHFFFAOYSA-N 0.000 description 2
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- HMZUUGCZNWUHKE-FRWWRKKXSA-N tert-butyl N-[1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]-N-[(4-iodo-2-nitrophenyl)methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C1=NC(N([C@H]2C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O2)[Si](C)(C)C(C)(C)C)C=C1)=O)CC1=C(C=C(C=C1)I)[N+](=O)[O-] HMZUUGCZNWUHKE-FRWWRKKXSA-N 0.000 description 2
- JRMUNVKIHCOMHV-UHFFFAOYSA-M tetrabutylammonium bromide Chemical compound [Br-].CCCC[N+](CCCC)(CCCC)CCCC JRMUNVKIHCOMHV-UHFFFAOYSA-M 0.000 description 2
- VDZOOKBUILJEDG-UHFFFAOYSA-M tetrabutylammonium hydroxide Chemical compound [OH-].CCCC[N+](CCCC)(CCCC)CCCC VDZOOKBUILJEDG-UHFFFAOYSA-M 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- QWVYNEUUYROOSZ-UHFFFAOYSA-N trioxido(oxo)vanadium;yttrium(3+) Chemical compound [Y+3].[O-][V]([O-])([O-])=O QWVYNEUUYROOSZ-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- BAPVAIYGEOPGKR-VDWGHMIBSA-N (2R,3R,5R)-3-[tert-butyl(dimethyl)silyl]-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-[6-[(2-nitrophenyl)methylamino]purin-9-yl]oxolan-3-ol Chemical compound [N+](=O)([O-])C1=C(CNC=2C=3N=CN([C@H]4C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O4)[Si](C)(C)C(C)(C)C)C=3N=CN=2)C=CC=C1 BAPVAIYGEOPGKR-VDWGHMIBSA-N 0.000 description 1
- IWGWYVZJYZUDKZ-VDWGHMIBSA-N (2R,3R,5R)-3-[tert-butyl(dimethyl)silyl]-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-[6-[(4-iodophenyl)methylamino]purin-9-yl]oxolan-3-ol Chemical compound IC1=CC=C(CNC=2C=3N=CN([C@H]4C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O4)[Si](C)(C)C(C)(C)C)C=3N=CN=2)C=C1 IWGWYVZJYZUDKZ-VDWGHMIBSA-N 0.000 description 1
- CWFFIVPIBSVNOC-BOYVUMAVSA-N (2R,3R,5R)-3-[tert-butyl(dimethyl)silyl]-2-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-[6-[(4-methoxy-2-nitrophenyl)methylamino]purin-9-yl]oxolan-3-ol Chemical compound COC1=CC(=C(CNC=2C=3N=CN([C@H]4C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O4)[Si](C)(C)C(C)(C)C)C=3N=CN=2)C=C1)[N+](=O)[O-] CWFFIVPIBSVNOC-BOYVUMAVSA-N 0.000 description 1
- JZSOVSXDMVJPTE-VDWGHMIBSA-N (2R,3R,5R)-5-[6-(benzylamino)purin-9-yl]-3-[tert-butyl(dimethyl)silyl]-2-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-3-ol Chemical compound C(C1=CC=CC=C1)NC=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1 JZSOVSXDMVJPTE-VDWGHMIBSA-N 0.000 description 1
- BXBWYASMNRMGOF-FILYFMJVSA-N (2R,3S,5R)-5-[6-amino-6-[(2-nitrophenyl)methyl]-8H-purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol Chemical compound [N+](=O)([O-])C1=C(CC2(C3=NCN([C@H]4C[C@H](O)[C@@H](CO)O4)C3=NC=N2)N)C=CC=C1 BXBWYASMNRMGOF-FILYFMJVSA-N 0.000 description 1
- RPWNMXPROMWYKP-WBALYPMMSA-N (2R,3S,5R)-5-[6-amino-6-[1-(4-iodophenyl)ethyl]-8H-purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol Chemical compound IC1=CC=C(C=C1)C(C)C1(C2=NCN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC=N1)N RPWNMXPROMWYKP-WBALYPMMSA-N 0.000 description 1
- RYCCADPMEVLUGZ-VWZUFWLJSA-N (2r,3s,5r)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol;diphosphono hydrogen phosphate Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O.C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 RYCCADPMEVLUGZ-VWZUFWLJSA-N 0.000 description 1
- ZWZDRDMQQQXUSV-YNEHKIRRSA-N (2r,3s,5r)-5-[2-amino-6-[(2-nitrophenyl)methoxy]purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol Chemical compound C=12N=CN([C@@H]3O[C@H](CO)[C@@H](O)C3)C2=NC(N)=NC=1OCC1=CC=CC=C1[N+]([O-])=O ZWZDRDMQQQXUSV-YNEHKIRRSA-N 0.000 description 1
- NIMQVHDXSYNJJX-BFHYXJOUSA-N (2r,3s,5r)-5-[6-(benzylamino)purin-9-yl]-2-(hydroxymethyl)oxolan-3-ol Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C=CC=CC=3)=C2N=C1 NIMQVHDXSYNJJX-BFHYXJOUSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- SUGXZLKUDLDTKX-UHFFFAOYSA-N 1-(2-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1[N+]([O-])=O SUGXZLKUDLDTKX-UHFFFAOYSA-N 0.000 description 1
- LLSXESRJJHAMAR-UHFFFAOYSA-N 1-(4-iodo-2-nitrophenyl)-2-methylpropan-1-ol Chemical compound CC(C)C(O)C1=CC=C(I)C=C1[N+]([O-])=O LLSXESRJJHAMAR-UHFFFAOYSA-N 0.000 description 1
- OUHXNNBLOOJLBY-UHFFFAOYSA-N 1-(4-iodo-2-nitrophenyl)propan-1-ol Chemical compound CCC(O)C1=CC=C(I)C=C1[N+]([O-])=O OUHXNNBLOOJLBY-UHFFFAOYSA-N 0.000 description 1
- YEHUCLPIVDFHKS-MBEZDYHHSA-N 1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-4-[(2-nitrophenyl)methylamino]pyrimidin-2-one Chemical compound [N+](=O)([O-])C1=C(CNC2=NC(N([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=C2)=O)C=CC=C1 YEHUCLPIVDFHKS-MBEZDYHHSA-N 0.000 description 1
- APVPIZBQJMIWGM-DRSNIGMVSA-N 1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C(=O)NC(=O)C(C)=C1)O APVPIZBQJMIWGM-DRSNIGMVSA-N 0.000 description 1
- XEQNWUPODWCTAB-RRFJBIMHSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[(2-nitrophenyl)methoxymethyl]pyrimidine-2,4-dione Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(COCC=2C(=CC=CC=2)[N+]([O-])=O)=C1 XEQNWUPODWCTAB-RRFJBIMHSA-N 0.000 description 1
- CBVVPMRIKQTBHA-PXVVHIOLSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-(2-nitrophenyl)ethoxymethyl]pyrimidine-2,4-dione Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 CBVVPMRIKQTBHA-PXVVHIOLSA-N 0.000 description 1
- RKNRGNIFDNWVIH-RVYFNJOASA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[1-(4-iodo-2-nitrophenyl)ethoxymethyl]pyrimidine-2,4-dione Chemical compound C=1C=C(I)C=C([N+]([O-])=O)C=1C(C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 RKNRGNIFDNWVIH-RVYFNJOASA-N 0.000 description 1
- LCMGQMHLQBFEOQ-LNAREIQUSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-[[2-methyl-1-(2-nitrophenyl)propoxy]methyl]pyrimidine-2,4-dione Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C(C)C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 LCMGQMHLQBFEOQ-LNAREIQUSA-N 0.000 description 1
- OSQFQCSVKRFRDG-RRFJBIMHSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-3-[(2-nitrophenyl)methyl]pyrimidine-2,4-dione Chemical compound O=C1N(CC=2C(=CC=CC=2)[N+]([O-])=O)C(=O)C(C)=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 OSQFQCSVKRFRDG-RRFJBIMHSA-N 0.000 description 1
- WSDPMJFJFGPSPV-XUVXKRRUSA-N 1-[(2r,4s,5r)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-5-methyl-3-[(2-nitrophenyl)methyl]pyrimidine-2,4-dione Chemical compound O=C1N(CC=2C(=CC=CC=2)[N+]([O-])=O)C(=O)C(C)=CN1[C@H]1C[C@H](O)[C@@H](CO[Si](C)(C)C(C)(C)C)O1 WSDPMJFJFGPSPV-XUVXKRRUSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- YKBGVTZYEHREMT-UHFFFAOYSA-N 2'-deoxyguanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1CC(O)C(CO)O1 YKBGVTZYEHREMT-UHFFFAOYSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- XBMJZNNQZGPBIW-HJMBMXFBSA-N 2,2,2-trifluoro-n-[3-[4-[1-[[1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]methoxy]ethyl]-3-nitrophenyl]prop-2-ynyl]acetamide Chemical compound C=1C=C(C#CCNC(=O)C(F)(F)F)C=C([N+]([O-])=O)C=1C(C)OCC(C(NC1=O)=O)=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 XBMJZNNQZGPBIW-HJMBMXFBSA-N 0.000 description 1
- VQEDXAKKOYSNBJ-RCCFBDPRSA-N 2,2,2-trifluoro-n-[3-[4-[[1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dioxopyrimidin-5-yl]methoxymethyl]-3-nitrophenyl]prop-2-ynyl]acetamide Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(COCC=2C(=CC(=CC=2)C#CCNC(=O)C(F)(F)F)[N+]([O-])=O)=C1 VQEDXAKKOYSNBJ-RCCFBDPRSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- JHVUDXUXQJOMBG-YTFSRNRJSA-N 9-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-6-[(2-nitrophenyl)methoxy]purin-2-amine Chemical compound C1[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O[C@H]1N1C2=NC(N)=NC(OCC=3C(=CC=CC=3)[N+]([O-])=O)=C2N=C1 JHVUDXUXQJOMBG-YTFSRNRJSA-N 0.000 description 1
- XRQGENZDIQBNRO-IXKUDPDQSA-N 9-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-n-[1-(4-iodophenyl)ethyl]purin-6-amine Chemical compound C=1C=C(I)C=CC=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O1 XRQGENZDIQBNRO-IXKUDPDQSA-N 0.000 description 1
- QLJRZZOXALZATI-LZLYRXPVSA-N C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NCC=2C(=CC(=CC=2)C#CCNC(=O)C(F)(F)F)[N+]([O-])=O)C=C1 Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)N=C(NCC=2C(=CC(=CC=2)C#CCNC(=O)C(F)(F)F)[N+]([O-])=O)C=C1 QLJRZZOXALZATI-LZLYRXPVSA-N 0.000 description 1
- UCNLAPSFMIZFNB-GVDBMIGSSA-N C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C(=CC(=CC=3)C#CCNC(=O)C(F)(F)F)[N+]([O-])=O)=C2N=C1 Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C(=CC(=CC=3)C#CCNC(=O)C(F)(F)F)[N+]([O-])=O)=C2N=C1 UCNLAPSFMIZFNB-GVDBMIGSSA-N 0.000 description 1
- MFMGBTALUVQJMC-BFHYXJOUSA-N C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C=CC(I)=CC=3)=C2N=C1 Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(NCC=3C=CC(I)=CC=3)=C2N=C1 MFMGBTALUVQJMC-BFHYXJOUSA-N 0.000 description 1
- YNJBUNWUGJOJIM-TVNQDGMRSA-N C=1C=C(C#CCNC(=O)C(F)(F)F)C=CC=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 Chemical compound C=1C=C(C#CCNC(=O)C(F)(F)F)C=CC=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 YNJBUNWUGJOJIM-TVNQDGMRSA-N 0.000 description 1
- QQELTAHSSGPITK-MOBHLTHFSA-N C=1C=C(I)C=CC=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 Chemical compound C=1C=C(I)C=CC=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 QQELTAHSSGPITK-MOBHLTHFSA-N 0.000 description 1
- SJENIJKRYBZDKQ-AIAHYXIJSA-N C=1C=CC=C([N+]([O-])=O)C=1C(C)NC(=NC1=O)C=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)NC(=NC1=O)C=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SJENIJKRYBZDKQ-AIAHYXIJSA-N 0.000 description 1
- YDMFLVSYJBQIOK-UHFFFAOYSA-N CC(C)OC(=O)[N+](=[N-])C(O)=O Chemical compound CC(C)OC(=O)[N+](=[N-])C(O)=O YDMFLVSYJBQIOK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- SSIDSAJVQXTLHQ-VBDKILDKSA-N FC(C(=O)NCC#CC1=CC(=C(CNC=2C=3N=C(N([C@]4(C[C@](O)([C@@H](COC(C)(C)C)O4)C(C)(C)C)[SiH3])C3N=C(N2)C)C)C=C1)[N+](=O)[O-])(F)F Chemical compound FC(C(=O)NCC#CC1=CC(=C(CNC=2C=3N=C(N([C@]4(C[C@](O)([C@@H](COC(C)(C)C)O4)C(C)(C)C)[SiH3])C3N=C(N2)C)C)C=C1)[N+](=O)[O-])(F)F SSIDSAJVQXTLHQ-VBDKILDKSA-N 0.000 description 1
- 208000009625 Lesch-Nyhan syndrome Diseases 0.000 description 1
- XISFYRSHVPOAOM-ZLIYTTPCSA-N N-[3-[4-[[[1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]amino]methyl]-3-nitrophenyl]prop-2-ynyl]-2,2,2-trifluoroacetamide Chemical compound FC(C(=O)NCC#CC1=CC(=C(CNC2=NC(N([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=C2)=O)C=C1)[N+](=O)[O-])(F)F XISFYRSHVPOAOM-ZLIYTTPCSA-N 0.000 description 1
- YEEGQOWCQMFHKH-HOZJOUCCSA-N N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]acetamide Chemical compound C(C)(=O)NC=1NC(C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=1)=O YEEGQOWCQMFHKH-HOZJOUCCSA-N 0.000 description 1
- 229910017852 NH2NH2 Inorganic materials 0.000 description 1
- 229910052779 Neodymium Inorganic materials 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 208000035317 Total hypoxanthine-guanine phosphoribosyl transferase deficiency Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- FBEHPMNCKUQUFR-BFHYXJOUSA-N [(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-[(2-nitrophenyl)methoxy]oxolan-2-yl]methanol Chemical compound O([C@H]1C[C@@H](O[C@@H]1CO)N1C=2N=CN=C(C=2N=C1)N)CC1=CC=CC=C1[N+]([O-])=O FBEHPMNCKUQUFR-BFHYXJOUSA-N 0.000 description 1
- CMHWWKXQDNEHBQ-RBZQAINGSA-N [2-amino-9-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]purin-6-yl] 2,4,6-trimethylbenzenesulfonate Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)OC1=NC(N)=NC2=C1N=CN2[C@@H]1O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C1 CMHWWKXQDNEHBQ-RBZQAINGSA-N 0.000 description 1
- VBTAWAFMGKZPGG-ISJGIBHGSA-N [9-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]purin-6-yl] 2,4,6-trimethylbenzenesulfonate Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)OC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C1 VBTAWAFMGKZPGG-ISJGIBHGSA-N 0.000 description 1
- XAKBSHICSHRJCL-UHFFFAOYSA-N [CH2]C(=O)C1=CC=CC=C1 Chemical group [CH2]C(=O)C1=CC=CC=C1 XAKBSHICSHRJCL-UHFFFAOYSA-N 0.000 description 1
- XPKHLLVXAOCXPI-AHHOBRAOSA-N [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1C(O)[Si](C)(C)C(C)(C)C)N1C(=O)NC(=O)C(=C1)COC(C)C1=C(C=CC=C1)[N+](=O)[O-])O Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1C(O)[Si](C)(C)C(C)(C)C)N1C(=O)NC(=O)C(=C1)COC(C)C1=C(C=CC=C1)[N+](=O)[O-])O XPKHLLVXAOCXPI-AHHOBRAOSA-N 0.000 description 1
- DLEHIZKGECTLMD-DOQJBMMISA-N [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C=NC=2C(=O)NC(N)=NC1=2)O Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C=NC=2C(=O)NC(N)=NC1=2)O DLEHIZKGECTLMD-DOQJBMMISA-N 0.000 description 1
- NIOLBERQNFYBFL-PXVVHIOLSA-N [[(2r,3s,5r)-5-[2-acetamido-6-[1-(2-nitrophenyl)ethoxy]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 NIOLBERQNFYBFL-PXVVHIOLSA-N 0.000 description 1
- WKWAFOQTKBMZKW-HJMBMXFBSA-N [[(2r,3s,5r)-5-[2-acetamido-6-[1-[2-nitro-4-[3-[(2,2,2-trifluoroacetyl)amino]prop-1-ynyl]phenyl]ethoxy]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCNC(=O)C(F)(F)F)C=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 WKWAFOQTKBMZKW-HJMBMXFBSA-N 0.000 description 1
- XOWOHISPWMNONN-TVNQDGMRSA-N [[(2r,3s,5r)-5-[6-[1-[4-(3-aminoprop-1-ynyl)phenyl]ethylamino]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCN)C=CC=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 XOWOHISPWMNONN-TVNQDGMRSA-N 0.000 description 1
- BPZHSNJGCYBPCR-GVDBMIGSSA-N [[(2r,3s,5r)-5-[6-[[4-(3-aminopropyl)phenyl]methylamino]purin-9-yl]-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=CC(CCCN)=CC=C1CNC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 BPZHSNJGCYBPCR-GVDBMIGSSA-N 0.000 description 1
- ZQXCUUDRFQSULI-AIAHYXIJSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[4-[1-(2-nitrophenyl)ethylamino]-2-oxopyrimidin-1-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)NC(=NC1=O)C=CN1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 ZQXCUUDRFQSULI-AIAHYXIJSA-N 0.000 description 1
- UUUDSOQCRXYLTB-MOBHLTHFSA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[6-[1-(2-nitrophenyl)ethylamino]purin-9-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 UUUDSOQCRXYLTB-MOBHLTHFSA-N 0.000 description 1
- XGYWDVUBRZOSPZ-RNEQGDNISA-N [hydroxy-[[(2r,3s,5r)-3-hydroxy-5-[6-[1-[2-nitro-4-[3-[(2,2,2-trifluoroacetyl)amino]prop-1-ynyl]phenyl]ethylamino]purin-9-yl]oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate Chemical compound C=1C=C(C#CCNC(=O)C(F)(F)F)C=C([N+]([O-])=O)C=1C(C)NC(C=1N=C2)=NC=NC=1N2[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 XGYWDVUBRZOSPZ-RNEQGDNISA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000002361 compost Substances 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052743 krypton Inorganic materials 0.000 description 1
- DNNSSWSSYDEUBZ-UHFFFAOYSA-N krypton atom Chemical compound [Kr] DNNSSWSSYDEUBZ-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- NLSHJPUSSJWJLL-HJMBMXFBSA-N n-[3-[4-[1-[2-acetamido-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]oxyethyl]-3-nitrophenyl]prop-2-ynyl]-2,2,2-trifluoroacetamide Chemical compound C=1C=C(C#CCNC(=O)C(F)(F)F)C=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 NLSHJPUSSJWJLL-HJMBMXFBSA-N 0.000 description 1
- XXBZRSPBYDXUQS-ARFHVFGLSA-N n-[3-[4-[[2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]oxymethyl]-3-nitrophenyl]prop-2-ynyl]-2,2,2-trifluoroacetamide Chemical compound C=12N=CN([C@@H]3O[C@H](CO)[C@@H](O)C3)C2=NC(N)=NC=1OCC1=CC=C(C#CCNC(=O)C(F)(F)F)C=C1[N+]([O-])=O XXBZRSPBYDXUQS-ARFHVFGLSA-N 0.000 description 1
- JTMVIKDARCEWMB-HEPOIJRFSA-N n-[9-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-6-[1-(2-nitrophenyl)ethoxy]purin-2-yl]acetamide Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O1 JTMVIKDARCEWMB-HEPOIJRFSA-N 0.000 description 1
- GZAPRIGZIHLLOJ-ZAZXJAEUSA-N n-[9-[(2r,4s,5r)-4-[tert-butyl(dimethyl)silyl]oxy-5-[[tert-butyl(dimethyl)silyl]oxymethyl]oxolan-2-yl]-6-[1-(4-iodo-2-nitrophenyl)ethoxy]purin-2-yl]acetamide Chemical compound C=1C=C(I)C=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](CO[Si](C)(C)C(C)(C)C)O1 GZAPRIGZIHLLOJ-ZAZXJAEUSA-N 0.000 description 1
- GQSXKMQNHBGUES-PXVVHIOLSA-N n-[9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[1-(2-nitrophenyl)ethoxy]purin-2-yl]acetamide Chemical compound C=1C=CC=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 GQSXKMQNHBGUES-PXVVHIOLSA-N 0.000 description 1
- GHORPOCAHFYDOC-RVYFNJOASA-N n-[9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-[1-(4-iodo-2-nitrophenyl)ethoxy]purin-2-yl]acetamide Chemical compound C=1C=C(I)C=C([N+]([O-])=O)C=1C(C)OC(C=1N=C2)=NC(NC(C)=O)=NC=1N2[C@H]1C[C@H](O)[C@@H](CO)O1 GHORPOCAHFYDOC-RVYFNJOASA-N 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 150000008300 phosphoramidites Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940043274 prophylactic drug Drugs 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000012205 qualitative assay Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000011451 sequencing strategy Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- GSBCJSCAALYBTM-SEXOINJZSA-N tert-butyl 3-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-5-methyl-2,6-dioxopyrimidine-1-carboxylate Chemical compound [Si](C)(C)(C(C)(C)C)[C@@]1(C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C(=O)N(C(=O)C(C)=C1)C(=O)OC(C)(C)C)O GSBCJSCAALYBTM-SEXOINJZSA-N 0.000 description 1
- HADXHOFABZFCPN-SEXOINJZSA-N tert-butyl 5-(bromomethyl)-3-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-2,6-dioxopyrimidine-1-carboxylate Chemical compound C(C)(C)(C)OC(=O)N1C(N([C@H]2C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O2)[Si](C)(C)C(C)(C)C)C=C(C1=O)CBr)=O HADXHOFABZFCPN-SEXOINJZSA-N 0.000 description 1
- DKVGIPXLMPLTJP-WFQUIRAASA-N tert-butyl 9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-6-[[2-nitro-4-[3-[(2,2,2-trifluoroacetyl)amino]prop-1-ynyl]phenyl]methylamino]-8H-purine-6-carboxylate Chemical compound C(C)(C)(C)OC(=O)C1(C2=NCN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C2=NC=N1)NCC1=C(C=C(C=C1)C#CCNC(C(F)(F)F)=O)[N+](=O)[O-] DKVGIPXLMPLTJP-WFQUIRAASA-N 0.000 description 1
- FFAOBOUIZDUFJN-FRWWRKKXSA-N tert-butyl N-[1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]-N-[(2-nitrophenyl)methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C1=NC(N([C@H]2C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O2)[Si](C)(C)C(C)(C)C)C=C1)=O)CC1=C(C=CC=C1)[N+](=O)[O-] FFAOBOUIZDUFJN-FRWWRKKXSA-N 0.000 description 1
- CMFMWPAUDHOOCC-FJOVFNDFSA-N tert-butyl N-[1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]-N-[[2-nitro-4-[3-[(2,2,2-trifluoroacetyl)amino]prop-1-ynyl]phenyl]methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C1=NC(N([C@H]2C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O2)[Si](C)(C)C(C)(C)C)C=C1)=O)CC1=C(C=C(C=C1)C#CCNC(C(F)(F)F)=O)[N+](=O)[O-] CMFMWPAUDHOOCC-FJOVFNDFSA-N 0.000 description 1
- XUGUQDVTANIIGN-YMJPAYASSA-N tert-butyl N-[1-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]-2-oxopyrimidin-4-yl]carbamate Chemical compound C(C)(C)(C)OC(=O)NC1=NC(N([C@H]2C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O2)[Si](C)(C)C(C)(C)C)C=C1)=O XUGUQDVTANIIGN-YMJPAYASSA-N 0.000 description 1
- RATZEXKLTDXUIY-VOSQCMCKSA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)C(=O)OC(C)(C)C RATZEXKLTDXUIY-VOSQCMCKSA-N 0.000 description 1
- LQHDFIUNKPZANV-WAWDLJLISA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[(2-nitrophenyl)methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)CC1=C(C=CC=C1)[N+](=O)[O-] LQHDFIUNKPZANV-WAWDLJLISA-N 0.000 description 1
- PAMTUMXXNUATJV-WAWDLJLISA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[(4-iodo-2-nitrophenyl)methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)CC1=C(C=C(C=C1)I)[N+](=O)[O-] PAMTUMXXNUATJV-WAWDLJLISA-N 0.000 description 1
- FXDCFECWOHZGHO-WAWDLJLISA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[(4-iodophenyl)methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)CC1=CC=C(C=C1)I FXDCFECWOHZGHO-WAWDLJLISA-N 0.000 description 1
- IUKGDFFEWFVOEV-DOBRQBTGSA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[(4-methoxy-2-nitrophenyl)methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)CC1=C(C=C(C=C1)OC)[N+](=O)[O-] IUKGDFFEWFVOEV-DOBRQBTGSA-N 0.000 description 1
- RUYPYHGNMKGILK-CZVCVAAJSA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[[2-nitro-4-[3-[(2,2,2-trifluoroacetyl)amino]prop-1-ynyl]phenyl]methyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)CC1=C(C=C(C=C1)C#CCNC(C(F)(F)F)=O)[N+](=O)[O-] RUYPYHGNMKGILK-CZVCVAAJSA-N 0.000 description 1
- ZXZBLWMUWQLVTR-DRGJWEBESA-N tert-butyl N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]carbamate Chemical compound C(C)(C)(C)OC(=O)NC=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1 ZXZBLWMUWQLVTR-DRGJWEBESA-N 0.000 description 1
- OAJFTPBHPQJKHR-RCCFBDPRSA-N tert-butyl N-[9-[(2R,4S,5R)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]-N-[(2-methylpropan-2-yl)oxycarbonyl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@H](O)[C@@H](CO[Si](C)(C)C(C)(C)C)O3)C=2N=CN=1)C(=O)OC(C)(C)C OAJFTPBHPQJKHR-RCCFBDPRSA-N 0.000 description 1
- ZGOBATDPTSGJKY-WAWDLJLISA-N tert-butyl N-benzyl-N-[9-[(2R,4R,5R)-4-[tert-butyl(dimethyl)silyl]-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-hydroxyoxolan-2-yl]purin-6-yl]carbamate Chemical compound C(C)(C)(C)OC(=O)N(C=1C=2N=CN([C@H]3C[C@](O)([C@@H](CO[Si](C)(C)C(C)(C)C)O3)[Si](C)(C)C(C)(C)C)C=2N=CN=1)CC1=CC=CC=C1 ZGOBATDPTSGJKY-WAWDLJLISA-N 0.000 description 1
- JAAZOOQHOPRBEW-YNEHKIRRSA-N tert-butyl n-[9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-6-yl]-n-[(2-methylpropan-2-yl)oxycarbonyl]carbamate Chemical compound C1=NC=2C(N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 JAAZOOQHOPRBEW-YNEHKIRRSA-N 0.000 description 1
- LHYHTGXFDBXIIN-ISJGIBHGSA-N tert-butyl n-[9-[(2r,4s,5r)-5-[[tert-butyl(dimethyl)silyl]oxymethyl]-4-[(2-nitrophenyl)methoxy]oxolan-2-yl]purin-6-yl]-n-[(2-methylpropan-2-yl)oxycarbonyl]carbamate Chemical compound O([C@H]1C[C@@H](O[C@@H]1CO[Si](C)(C)C(C)(C)C)N1C=2N=CN=C(C=2N=C1)N(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)CC1=CC=CC=C1[N+]([O-])=O LHYHTGXFDBXIIN-ISJGIBHGSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/567,193 US7893227B2 (en) | 2006-12-05 | 2006-12-05 | 3′-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing |
| US11/567,189 | 2006-12-05 | ||
| US11/567,189 US7897737B2 (en) | 2006-12-05 | 2006-12-05 | 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing |
| US11/567,193 | 2006-12-05 | ||
| PCT/US2007/086559 WO2008070749A2 (en) | 2006-12-05 | 2007-12-05 | Photocleavable labeled nucleotides and nucleosides and labeled nucleotides and nucleosides and methods for their use in dna sequencing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0719923A2 BRPI0719923A2 (pt) | 2014-03-04 |
| BRPI0719923B1 true BRPI0719923B1 (pt) | 2021-08-17 |
Family
ID=39493724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0719923-6A BRPI0719923B1 (pt) | 2006-12-05 | 2007-12-05 | Métodos para sequenciamento de um ácido nucléico alvo, para conversão de um componente de ocorrência não natural em uma molécula de ácido nucléico em um componente de ocorrência natural, para terminar uma síntese de ácido nucléico, e para realizar o sequenciamento de sanger ou tipo sanger, e compostos |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2125856B1 (https=) |
| JP (1) | JP5513122B2 (https=) |
| KR (1) | KR101504640B1 (https=) |
| CN (1) | CN102443030B (https=) |
| AU (1) | AU2007329361B2 (https=) |
| BR (1) | BRPI0719923B1 (https=) |
| CA (1) | CA2670937C (https=) |
| IL (1) | IL199051A (https=) |
| MX (2) | MX338089B (https=) |
| NZ (1) | NZ577303A (https=) |
| RU (1) | RU2009121089A (https=) |
| WO (1) | WO2008070749A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7897737B2 (en) | 2006-12-05 | 2011-03-01 | Lasergen, Inc. | 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing |
| NZ590265A (en) | 2008-06-11 | 2012-11-30 | Lasergen Inc | Nucleotides and nucleosides and methods for their use in dna sequencing |
| EP2321429B1 (en) | 2008-09-03 | 2016-08-17 | Quantumdx Group Limited | Methods and kits for nucleic acid sequencing |
| US10759824B2 (en) | 2008-09-03 | 2020-09-01 | Quantumdx Group Limited | Design, synthesis and use of synthetic nucleotides comprising charge mass tags |
| WO2013040257A1 (en) | 2011-09-13 | 2013-03-21 | Lasergen, Inc. | 5-methoxy. 3'-oh unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing |
| WO2013105025A1 (en) * | 2012-01-13 | 2013-07-18 | Koninklijke Philips N.V. | Dna sequencing with reagent recycling on wiregrid |
| CN103602719B (zh) * | 2013-04-07 | 2016-06-08 | 北京迈基诺基因科技有限责任公司 | 一种基因测序方法 |
| WO2015015913A1 (ja) * | 2013-07-31 | 2015-02-05 | 株式会社 日立ハイテクノロジーズ | 核酸分析用フローセル、及び核酸分析装置 |
| GB201414098D0 (en) | 2014-08-08 | 2014-09-24 | Illumina Cambridge Ltd | Modified nucleotide linkers |
| RU2582198C1 (ru) * | 2014-11-20 | 2016-04-20 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделения Российской академии наук (ЛИН СО РАН) | Аналоги природных дезоксирибонуклеозидтрифосфатов и рибонуклеозидтрифосфатов, содержащие репортёрные флуоресцентные группы, для использования в аналитической биоорганической химии |
| CN105001292A (zh) * | 2015-07-14 | 2015-10-28 | 深圳市瀚海基因生物科技有限公司 | 一种光可断裂的荧光标记可逆终端化合物及其在dna或rna测序中的用途 |
| EP3400444A4 (en) | 2016-01-04 | 2019-10-16 | QuantuMDx Group Limited | DESIGN, SYNTHESIS AND USE OF SYNTHETIC NUCLEOTIDES WITH LOADING MASS MARKINGS |
| GB201711219D0 (en) | 2017-07-12 | 2017-08-23 | Illumina Cambridge Ltd | Short pendant arm linkers for nucleotides in sequencing applications |
| CN113272443B (zh) | 2019-01-07 | 2025-01-10 | 安捷伦科技有限公司 | 用于单细胞中的基因组dna和基因表达分析的组合物和方法 |
| CN110568039B (zh) * | 2019-09-06 | 2021-05-04 | 中国科学院生物物理研究所 | 使用新型电化学传感器的氨基酸特异实时检测方法 |
| WO2021194640A1 (en) * | 2020-03-26 | 2021-09-30 | Agilent Technologies, Inc. | Methods and compositions for multistage primer extension reactions |
| GB2605404A (en) * | 2021-03-30 | 2022-10-05 | Sumitomo Chemical Co | Sequencing method |
| WO2022263489A1 (en) * | 2021-06-17 | 2022-12-22 | F. Hoffmann-La Roche Ag | Nucleoside-5 -oligophosphates having a cationically-modified nucleobase |
| IL309368A (en) * | 2021-06-29 | 2024-02-01 | Agilent Technologies Inc | polymerase mutants and use with 3'-OH UNBLOCKED REVERSIBLE TERMINATORS |
| CN114250283B (zh) * | 2021-10-15 | 2022-10-04 | 深圳铭毅智造科技有限公司 | 基于环境敏感染料的单色荧光mrt基因测序试剂及方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5302509A (en) * | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
| YU187991A (sh) * | 1990-12-11 | 1994-09-09 | Hoechst Aktiengesellschaft | 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba |
| US6211165B1 (en) * | 1997-05-09 | 2001-04-03 | The Trustees Of The University Of Pennsylvania | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
| US6586413B2 (en) * | 1999-11-05 | 2003-07-01 | The United States Of America As Represented By The Department Of Health And Human Services | Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists |
| AU2001296645A1 (en) | 2000-10-06 | 2002-04-15 | The Trustees Of Columbia University In The City Of New York | Massive parallel method for decoding dna and rna |
| DE60212642T2 (de) * | 2001-04-10 | 2007-06-14 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | Verfahren zur verwendung von o6-alkylguanin-dna-alkyltransferasen |
| GB0128526D0 (en) * | 2001-11-29 | 2002-01-23 | Amersham Pharm Biotech Uk Ltd | Nucleotide analogues |
| US7057026B2 (en) * | 2001-12-04 | 2006-06-06 | Solexa Limited | Labelled nucleotides |
| PT3438116T (pt) | 2002-08-23 | 2021-03-23 | Illumina Cambridge Ltd | Nucleótidos identificados |
| CZ294538B6 (cs) * | 2002-12-30 | 2005-01-12 | Ústav Experimentální Botaniky Akademie Vědčeské Re | Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující |
| EP2436778A3 (en) * | 2004-03-03 | 2012-07-11 | The Trustees of Columbia University in the City of New York | Photocleavable fluorescent nucleotides for DNA sequencing on chip constructed by site-specific coupling chemistry |
-
2007
- 2007-12-05 KR KR1020097013028A patent/KR101504640B1/ko active Active
- 2007-12-05 NZ NZ577303A patent/NZ577303A/en not_active IP Right Cessation
- 2007-12-05 EP EP07854973.0A patent/EP2125856B1/en active Active
- 2007-12-05 RU RU2009121089/04A patent/RU2009121089A/ru not_active Application Discontinuation
- 2007-12-05 CA CA2670937A patent/CA2670937C/en active Active
- 2007-12-05 MX MX2011013323A patent/MX338089B/es unknown
- 2007-12-05 MX MX2009005936A patent/MX2009005936A/es active IP Right Grant
- 2007-12-05 JP JP2009540462A patent/JP5513122B2/ja active Active
- 2007-12-05 AU AU2007329361A patent/AU2007329361B2/en active Active
- 2007-12-05 CN CN201110376726.1A patent/CN102443030B/zh active Active
- 2007-12-05 WO PCT/US2007/086559 patent/WO2008070749A2/en not_active Ceased
- 2007-12-05 BR BRPI0719923-6A patent/BRPI0719923B1/pt active IP Right Grant
-
2009
- 2009-06-01 IL IL199051A patent/IL199051A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL199051A (en) | 2013-11-28 |
| AU2007329361A1 (en) | 2008-06-12 |
| JP5513122B2 (ja) | 2014-06-04 |
| CA2670937C (en) | 2016-07-26 |
| RU2009121089A (ru) | 2011-01-20 |
| MX338089B (es) | 2016-04-01 |
| CN102443030A (zh) | 2012-05-09 |
| BRPI0719923A2 (pt) | 2014-03-04 |
| EP2125856A2 (en) | 2009-12-02 |
| CN102443030B (zh) | 2015-12-16 |
| AU2007329361B2 (en) | 2013-07-18 |
| CA2670937A1 (en) | 2008-06-12 |
| KR101504640B1 (ko) | 2015-03-20 |
| MX2009005936A (es) | 2010-01-15 |
| WO2008070749A2 (en) | 2008-06-12 |
| JP2011506265A (ja) | 2011-03-03 |
| HK1169413A1 (zh) | 2013-01-25 |
| EP2125856B1 (en) | 2016-09-14 |
| NZ577303A (en) | 2011-12-22 |
| WO2008070749A3 (en) | 2008-11-27 |
| KR20090101451A (ko) | 2009-09-28 |
| EP2125856A4 (en) | 2013-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0719923B1 (pt) | Métodos para sequenciamento de um ácido nucléico alvo, para conversão de um componente de ocorrência não natural em uma molécula de ácido nucléico em um componente de ocorrência natural, para terminar uma síntese de ácido nucléico, e para realizar o sequenciamento de sanger ou tipo sanger, e compostos | |
| US8969535B2 (en) | Photocleavable labeled nucleotides and nucleosides and methods for their use in DNA sequencing | |
| US8198029B2 (en) | 3'-OH unblocked nucleotides and nucleosides base modified with non-cleavable, terminating groups and methods for their use in DNA sequencing | |
| CN110709089B (zh) | 用于连接荧光标记与用于dna合成测序的碱基的具有不同可裂解连接子的3’-o-改性的核苷酸类似物 | |
| US7238795B2 (en) | Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses | |
| EP2089343B1 (en) | Click chemistry for the production of reporter molecules | |
| JPH07504087A (ja) | 蛍光性n−ヌクレオシド及び蛍光性n−ヌクレオシド構造類似体の応用 | |
| IE914301A1 (en) | 3'- amino- or thiol-modified, fluorescent dye-coupled nucleoside and oligonucleotide, a process for their preparation and their use | |
| JP5781589B2 (ja) | 光開裂性標識ヌクレオチドとヌクレオシドおよび標識ヌクレオチドとヌクレオシドならびにdna配列決定におけるそれらの使用法 | |
| WO2025152366A1 (zh) | 一种核苷酸衍生物及其应用 | |
| Stolze et al. | Synthesis of 3′‐Sugar‐and Base‐Modified Nucleotides and Their Application as Potent Chain Terminators in DNA Sequencing | |
| JP4510628B2 (ja) | 末端リン酸ブロックヌクレオシドポリリン酸 | |
| HK1169413B (en) | Photocleavable labeled nucleotides and nucleosides and labeled nucleotides and nucleosides and methods for their use in dna sequencing | |
| BR112019027614A2 (pt) | ligantes de braços pendentes curtos para nucleotídeos em aplicações de sequenciamento | |
| NZ622268A (en) | 5-methoxy, 3’-oh unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing | |
| HK1195076A (en) | Nucleotides and nucleosides and methods for their use in dna sequencing | |
| JPWO2004058793A1 (ja) | ヌクレオチド誘導体とdnaマイクロアレイ | |
| HK1163184A1 (en) | Nucleotides and nucleosides and methods for their use in dna sequencing | |
| NZ622268B2 (en) | 5-methoxy, 3'-oh unblocked, fast photocleavable terminating nucleotides and methods for nucleic acid sequencing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: AGILENT TECHNOLOGIES INC. (US) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/12/2007, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |